Daily SPAC Update – May 15, 2024

by | May 15, 2024

LIBY + Caspi Oil Gas Deal Terminated. GTAC + Tyfon and BFAC + Class Over Deals Announced. CHAA Extension Vote. BLAC Extension Approved w/ 1.6m Redemptions.

Boardroom Alpha SPAC Resources
Full SPAC Listing
SPAC SEC Filings
Boardroom Alpha IPO & SPAC Intelligence Platform (7-Day Trial)

Daily SPAC Update

SPAC DEALS ANNOUNCED
GTAC + Tyfon Culture Holdings Limited
BFAC + Class Over Inc.

SPAC DEAL TERMINATIONS
LIBY + Caspi Oil Gas LLP

EXTENSION VOTES
CHAA – CATCHA INVESTMENT CORP * vote May 15, 2024 -> extend 3 times monthly to August 2024

SPAC VOTE RESULTS
BLAC – BELLEVUE LIFE SCIENCES ACQUISITION CORP * Extend to Nov 14, 2024 * 1,581,733 redeemed

SPAC VOTES SET
BOCN – BLUE OCEAN ACQUISITION CORP * Extension Vote Set: May 29, 2024 * trust $11.10
TWLV – TWELVE SEAS INVESTMENT CO II * Extension Vote Set: May 28, 2024 * trust $10.82
CVII – CHURCHILL CAPITAL CORP VII * Changing vote date; TBD
SUAC – SHOULDERUP TECHNOLOGY ACQUISITION CORP * Vote delayed to May 17, 2024

OTHER SPAC NEWS
BFAC – BATTERY FUTURE ACQUISITION CORP * Trust Update * trust $11.13
BFAC – BATTERY FUTURE ACQUISITION CORP * Merger Agreement Amendment

YESTERDAY’S TOP SPAC GAINERS
18.16% ~ $ 9.11 | PLTN – Plutonian Acquisition Corp. (Announced)
3.88% ~ $ 13.40 | ADRT – Ault Disruptive Technologies Corp (Pre-Deal)
3.57% ~ $ 6.25 | RWOD – Redwoods Acquisition Corp. (Announced)
2.46% ~ $ 11.89 | DHAC – Digital Health Acquisition Corp. (Announced)
2.39% ~ $ 12.00 | HUDA – Hudson Acquisition I Corp. (Pre-Deal)

YESTERDAY’S TOP SPAC LOSERS
-12.28% ~ $ 9.86 | USCT – TKB Critical Technologies 1 (Pre-Deal)
-8.62% ~ $ 10.18 | SCRM – Screaming Eagle Acquisition Corp. (Announced)
-7.86% ~ $ 11.52 | NVAC – NorthView Acquisition Corp (Announced)
-4.18% ~ $ 11.45 | FHLT – Future Health ESG Corp. (Pre-Deal)
-3.45% ~ $ 8.40 | BITE – Bite Acquisition Corp. (Announced)

Recent Analysis

Daily SPAC Update – December 10, 2024

Jackson Acquisition II $200M IPO (Jackson I Liquidated). APXI Shareholders Approve Extension w/ 5M Redemptions. HCVI Merger Amendment. SLAMF Vote Adjourned and IVCB Vote Postponed. 

Daily SPAC Update – December 9, 2024

TCHP + Coincheck Deal Approved. GLLI, INAQ, ESHA Shareholders Approve Extensions. DP Cap Acquisition  (DPCS) Dismisses Accountant. SLAM and BRKH Extension Votes.

Daily SPAC Update – December 4, 2024

Global Star (GLST) Extension Approved. APXI Extension Vote Today. ATMC Updates Trust Numbers. LATG Deal Vote Set for Dec 23. ATMV, SHAP, TRON, INAQ Set Extension Votes.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.